Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its primary ...
Jan 28 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab spent nearly $500 million on U.S. advertising for its GLP-1 drugs Wegovy and Ozempic in the first nine months of 2025, more than double what ...
Find historical weather by searching for a city, zip code, or airport code. Include a date for which you would like to see weather history. You can select a range of dates in the results on the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results